Oncologists; hematologists; Nurse Practitioners (NPs); Physician Assistants (PAs); and other clinicians who care for patients being treated for oncological and hematological diseases.
Rasim A. Gucalp, MD, FACP
Course Director and Moderator
Rasim A. Gucalp, MD, FACP
Professor, Department of Medicine (Oncology)
Albert Einstein College of Medicine
Director, Hematology/Oncology Fellowship Program
Montefiore Medical Center
Bronx, NY
Dr. Rasim Gucalp’s research interests include novel therapies in lung cancer as well as supportive care in cancer patients. He is actively involved in the multidisciplinary care of patients with lung cancer and central nervous system tumors. He is a member of several Montefiore Medical Center/Albert Einstein College of Medicine committees including the institutional tumor board, faculty senate, Pharmacy and Therapeutic Committee, and COGME.
A native of Turkey, Dr. Gucalp received his medical degree at Hacettepe University School of Medicine in Ankara, Turkey. After completing his medical residency at Downstate Medical Center in Brooklyn, he came to Montefiore Medical Center to complete his oncology fellowship. He is associate chairman of Department Oncology for educational activities and the director of the Hematology/Oncology Fellowship Program at Montefiore, and serves as a Professsor of Medicine at Albert Einstein College of Medicine.
Noah Kornblum, MD
Noah Kornblum, MD
Assistant Professor, Department of Medicine (Oncology)
Bone Marrow Transplant/Heme Malignancy
Montefiore Einstein Center for Cancer Care
Bronx, NY
Dr. Kornblum graduated from the Sackler School of Medicine in 1999. Dr. Kornblum works in Bronx, NY and 2 other locations and specializes in Medical Oncology. Dr. Kornblum is affiliated with Montefiore Medical Center Einstein Campus and Montefiore Medical Center.
1. | Identify emerging treatment options for myeloma patients at advanced relapse. | 2. | Assess B-cell maturation antigen (BCMA) as a therapeutic target in patients at advanced relapse. |
3. | Compare the efficacy and safety of investigational agents targeting B-cell maturation antigen (BCMA) in relapsed myeloma patients. |
1. | Identify emerging treatment options for myeloma patients at advanced relapse. |
2. | Assess B-cell maturation antigen (BCMA) as a therapeutic target in patients at advanced relapse. |
3. | Compare the efficacy and safety of investigational agents targeting B-cell maturation antigen (BCMA) in relapsed myeloma patients. |
This activity is presented by Albert Einstein College of Medicine-Montefiore Medical Center in Collaboration with NACE
Summary
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Privacy
Albert Einstein College of Medicine-Montefiore Medical Center, Center for Continuing Professional Development protects the privacy of personal and other information regarding participants and educational collaborators. We will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting to the ACCME.
Albert Einstein College of Medicine-Montefiore Medical Center, Center for Continuing Professional Development maintains physical, electronic, and procedural safeguards that comply with federal regulations to protect against the loss, misuse, or alteration of information collected from you.
Additional information regarding Albert Einstein College of Medicine-Montefiore Medical Center's Privacy Policy can be viewed at https://www.mecme.org/PrivacyStatement.aspx.
COURSE VIEWING REQUIREMENTS
Supported Browsers: Internet Explorer 8.0+ for Windows 2000, 2003, Vista, XP, Windows 7, Windows 8 and above Google Chrome 28.0+ for Windows, Mac OS, or Linux Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux Safari 6+ for Mac OSX 10.7 and above For video playback, install the latest version of Flash or Quicktime. | Supported Phones & Tablets: Android 4.0.3 and above iPhone/iPad with iOS 6.1 or above |